INDOL-3-CARBINOL IN THE TREATMENT OF BENIGN BREAST DISORDERS
123 patients with various forms of fibrocystic mastopathy (n=114) and fibroadenoma of mammry gland (n=9) were enrolled into the study. Indol-3-carbinol (indinol, Close corporation «Mirax-Pharma») was administered in the dose of 300-400 mg per day for 3-6 months. Disappearance of complaints to pain w...
Saved in:
Main Authors: | E. T. Zulkarnayeva (Author), R. H. Hakimova (Author), Ye. A. Lapan (Author), I. L. Blagodetelev (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytotoxic and antibacterial polyketide-indole hybrids synthesized from indole-3-carbinol by Daldinia eschscholzii
by: Liping Lin, et al.
Published: (2019) -
Analysis of indole- 3 - carbinole (an anticainogenic agent in cruciferae) by linary sweep voltammetry
by: (Pharm .D.), et al.
Published: (2003) -
Serum glutathione transferase does not respond to indole-3-carbinol: A pilot study
by: Daniel R McGrath, et al.
Published: (2010) -
Synthetic Methodologies and Therapeutic Potential of Indole-3-Carbinol (I3C) and Its Derivatives
by: Federica Centofanti, et al.
Published: (2023) -
Synergistic Apoptotic Effect Of Indole-3-Carbinol And Doxorubicin On Pre-B Acute Lymphoblastic Leukemia Cells
by: Behnaz Tavasoli, et al.
Published: (2015)